Furthermore, recent reports have revealed that both GM-CSF and GM-CSF receptors are increased and correlated with disease severity in many inflammatory and autoimmune diseases, such as inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, and SARS-CoV-2 [50,51]. The gene discussed is CSF2; the disease is inflammatory bowel disease.